12. Earnings per Share
|
Year ended December 31 |
|
|---|---|---|
|
2024 |
2023 |
Net profit attributable to owners of the parent |
74,082 |
211,697 |
|
|
|
Number of shares (thousands) |
|
|
Weighted average number of shares for the purpose of basic earnings / loss (-) per share |
65,897 |
65,884 |
|
|
|
Basic earnings per share (€) |
1.12 |
3.21 |
|
|
|
Net profit attributable to owners of the parent |
74,082 |
211,697 |
|
|
|
Number of shares (thousands) |
|
|
Weighted average number of shares for the purpose of diluted earnings / loss (-) per share |
65,897 |
65,884 |
Number of dilutive potential ordinary shares |
45 |
49 |
|
|
|
Diluted earnings per share (€) |
1.12 |
3.21 |
Reference is also made to note 2 where an explanation is provided about the terms and conditions of the outstanding subsequent Gilead Warrant B that can, potentially, be exercised by Gilead and lead to a dilutive effect. Due to the exercise price mechanism of the Gilead Warrant B, this warrant was out-of-the-money for 2024 and 2023.